Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

Archive ouverte

Buske, C. | Dreyling, M. | Alvarez-Larrán, A. | Apperley, J. | Arcaini, L. | Besson, C. | Bullinger, L. | Corradini, P. | Giovanni Della Porta, M. | Dimopoulos, M. | D’sa, S. | Eich, H.T. | Foà, R. | Ghia, P. | da Silva, M.G. | Gribben, J. | Hajek, R. | Harrison, C. | Heuser, M. | Kiesewetter, B. | Kiladjian, J.J. | Kröger, N. | Moreau, P. | Passweg, J.R. | Peyvandi, F. | Rea, D. | Ribera, J.-M. | Robak, T. | San-Miguel, J.F. | Santini, V. | Sanz, G. | Sonneveld, P. | von Lilienfeld-Toal, M. | Wendtner, C. | Pentheroudakis, G. | Passamonti, F.

Edité par CCSD ; European Society for Medical Oncology -

International audience. Background: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. Methods: This consensus manuscript aims at discussing clinical evidence and providing expert advice on statements related to the management of HMs in the COVID-19 pandemic. For this purpose, an international consortium was established including a steering committee, which prepared six working packages addressing significant clinical questions from the COVID-19 diagnosis, treatment, and mitigation strategies to specific HMs management in the pandemic. During a virtual consensus meeting, including global experts and lead by the European Society for Medical Oncology and the European Hematology Association, statements were discussed and voted upon. When a consensus could not be reached, the panel revised statements to develop consensual clinical guidance. Results and conclusion: The expert panel agreed on 33 statements, reflecting a consensus, which will guide clinical decision making for patients with hematological neoplasms during the COVID-19 pandemic.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion